Patents Represented by Attorney, Agent or Law Firm Sandra Kuzmich
  • High specificity anticancer agents
    Patent number: 6767919
    Abstract: A process for producing new anticancer drugs such that the drugs can be administered in a nontoxic, proto-drug form and, subsequent to a time delay which allows for differential concentration in the target cancer or invasive tissues or cells, the non-toxic drug is then modified by an activation drug to selectively provide toxic levels of a pharmacologically active agent to the target issue.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: July 27, 2004
    Assignee: Walker Cancer Research Institute, Inc.
    Inventors: Evan Harris Walker, Eduardo Palomino, Steven L. Blumenthal